BCP BC5 Highly efficient purity 99%
TDS
1628202-19-6
Pharmaceutical Grade
99.55%
shenzhen
AoXin
5mg/vial,10vials/box
2026-09-05
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Description
-
Seller Information
-
History Price
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
BPC 157 (acetate)
CAS No.:1628202-19-6
Categories:
Research-
Class:
Pentadecapeptide (gastric juice-derived protective peptide)
Status:Research compound — Not FDA approved (FDA PCAC under review 2025–2026)
Mechanism:A stable, orally active 15-amino-acid peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) originally isolated from human gastric juice. BPC-157 promotes wound healing, angiogenesis, and tissue regeneration through upregulation of VEGF, nitric oxide (NO) synthesis, and modulation of the JAK/STAT, MAPK/ERK, and FAK-paxillin pathways. It does not act via a single receptor but through multi-pathway cytoprotective signaling.
Activity note:BPC-157 is a multi-pathway cytoprotective peptide, not a single-receptor agonist. Functional effects are observed from ng/kg to μg/kg in vivo. No single EC₅₀ value is applicable.
Source:Sikirić P, et al. Curr Pharm Des. 2018;24(18):1997–2007. NCATS Inxight: BPC-157 (UNII 8ED8NXK95P).DOI
Clinical Development:
References-
PubChem:UNII:Literature:
NCATS Inxight: BPC-157 (UNII 8ED8NXK95P); FDA PCAC: BPC-157 Nomination Briefing (2025–2026); Curr Pharm Des: Sikirić P et al. (2018) — Review
Disclaimer:BPC-157 is NOT FDA-approved or EMA-approved. It is a research compound only. The FDA Pharmacy Compounding Advisory Committee (PCAC) is reviewing BPC-157 for potential inclusion on the 503A bulks list as of 2025–2026. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
Room 1402, Unit 1, Building 1, Hongxing Mansion, Shanghang Road Sub-district, Hedong District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product